KORU MEDICAL SYSTEMS


Associated tags: Flo, Patient, Quality of life, FREEDOM, Health, Medical Devices, Medical Supplies, Pharmaceutical, KRMD, Pharmaceutical industry, KORU, Health Technology

Locations: MINNEAPOLIS, ALBANY, EUROPEAN UNION, TEXAS, US, NEW JERSEY, UNITED STATES, NORTH AMERICA, LINDA, EUROPE

KORU Medical Prices Public Offering of Common Stock

Retrieved on: 
Friday, June 19, 2020
Managed care, Health, Medical Supplies, Underwriting, Actuarial science, Koru, Finance, Money, Stock market, Economy

Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (KORU Medical) today announced the pricing of its previously announced underwritten public offering of 3,125,000 shares of its common stock at a public offering price of $8.00 per share.

Key Points: 
  • Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (KORU Medical) today announced the pricing of its previously announced underwritten public offering of 3,125,000 shares of its common stock at a public offering price of $8.00 per share.
  • The gross proceeds to KORU Medical before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $25 million.
  • In connection with the offering, KORU Medical has granted the underwriters a 30-day option to purchase up to an additional 468,750 shares at the public offering price, less underwriting discounts and commissions.
  • KORU Medical currently intends to use the net proceeds from this offering primarily for general corporate purposes and working capital.

KORU Medical Commences Public Offering of Common Stock

Retrieved on: 
Thursday, June 18, 2020
Medical devices, Health, Financial economics, Finance, Economy, Prospectus, Public offering, Koru

Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (KORU Medical) today announced that it has commenced an underwritten public offering of the sale of its shares of common stock.

Key Points: 
  • Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (KORU Medical) today announced that it has commenced an underwritten public offering of the sale of its shares of common stock.
  • In connection with this offering, KORU Medical intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the public offering.
  • KORU Medical currently intends to use the net proceeds from this offering primarily for general corporate purposes and working capital.
  • Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that KORU Medical has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about KORU Medical and such offering.